Medicare Enrolled

Dr. Noor Sachdev, MD

Neurology · San Jose, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
2520 SAMARITAN DR STE 201B, San Jose, CA 95124
4083567810
In practice since 2008 (17 years)
NPI: 1710141072 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sachdev from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sachdev? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sachdev

Dr. Noor Sachdev is a neurology specialist in San Jose, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Sachdev performed 14,922 Medicare services across 558 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sachdev received a total of $214,037 from 84 pharmaceutical and/or device companies across 1526 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sachdev is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 7% volume in CA $214,037 industry payments

Medicare Practice Summary

Medicare Utilization ↗
14,922
Medicare services
Top 7% in CA for neurology
558
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~878 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
14,200 $5 $15
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
309 $160 $635
New patient office visit, complex (60-74 min) 97 $180 $770
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
68 $116 $460
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
44 $101 $350
Chemical nerve block for facial paralysis
Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face.
42 $200 $916
Psychological or neuropsychological test, first 30 minutes
Administration of psychological or neuropsychological testing for the first 30 minutes.
42 $42 $175
Additional 30 minutes of psychological or neuropsychological testing
This code represents an additional 30-minute increment for administering psychological or neuropsychological tests. It is used to bill for time beyond the initial testing period.
42 $39 $165
Neuropsychological test evaluation, first hour
A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process.
41 $120 $443
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
19 $86 $325
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
18 $238 $757
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$214,037
Total received (2018-2024)
Avg $30,577/year across 7 years
Top 4% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
1,526
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$181,219 (84.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,091 (11.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,727 (4.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$39,657
2023
$39,740
2022
$38,338
2021
$50,396
2020
$17,545
2019
$22,461
2018
$5,900

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$29,771
Lundbeck LLC
$6,159
Lilly USA, LLC
$395
Alexion Pharmaceuticals, Inc.
$319
Novartis Pharmaceuticals Corporation
$278
SK Life Science, Inc.
$249
UCB, Inc.
$245
Neurelis, Inc.
$235
ARGENX US, INC.
$228
Biogen, Inc.
$205
Teva Pharmaceuticals USA, Inc.
$181
PFIZER INC.
$177
CATALYST PHARMACEUTICALS, INC.
$168
Eisai Inc.
$125
Amgen Inc.
$108
CSL Behring
$92
Octapharma USA, Inc.
$81
Acorda Therapeutics, Inc
$79
Takeda Pharmaceuticals U.S.A., Inc.
$75
HOSPIRA, INC.
$65
EMD Serono, Inc.
$65
Celgene Corporation
$62
Harmony Biosciences Llc
$39
Neurocrine Biosciences, Inc.
$36
ACADIA Pharmaceuticals Inc
$31
MITSUBISHI TANABE PHARMA AMERICA, INC.
$31
Alnylam Pharmaceuticals Inc.
$29
Sumitomo Pharma America, Inc.
$29
Kyowa Kirin, Inc.
$23
Otsuka America Pharmaceutical, Inc.
$23
BANNER LIFE SCIENCES, LLC
$19
Genentech USA, Inc.
$19
Mallinckrodt Hospital Products Inc.
$18
Top 3 companies account for 91.6% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$52,415
AbbVie Inc.
$42,227
Amgen Inc.
$25,479
Teva Pharmaceuticals USA, Inc.
$20,801
Biohaven Pharmaceuticals, Inc.
$17,152
Alexion Pharmaceuticals, Inc.
$12,707
ARGENX US, INC.
$6,879
Lundbeck LLC
$6,777
Biohaven Pharmaceutical Holding Company Ltd.
$5,665
Allergan, Inc.
$2,486
UCB, Inc.
$2,028
Novartis Pharmaceuticals Corporation
$1,727
Biogen, Inc.
$1,670
SK Life Science, Inc.
$1,219
LivaNova USA, Inc.
$1,039
Eisai Inc.
$918
Lilly USA, LLC
$918
Allergan Inc.
$780
Janssen Pharmaceuticals, Inc
$694
Genentech USA, Inc.
$613
CSL Behring
$549
PFIZER INC.
$508
Neurocrine Biosciences, Inc.
$494
EMD Serono, Inc.
$481
EISAI INC.
$477
Horizon Therapeutics plc
$417
Avanir Pharmaceuticals, Inc.
$401
Sunovion Pharmaceuticals Inc.
$368
Neurelis, Inc.
$362
GENZYME CORPORATION
$334
US WorldMeds, LLC
$333
IMPEL PHARMACEUTICALS INC.
$324
Acorda Therapeutics, Inc
$301
Kyowa Kirin, Inc.
$252
ACADIA Pharmaceuticals Inc
$248
Sumitomo Pharma America, Inc.
$242
Harmony Biosciences LLC
$236
Akcea Therapeutics, Inc.
$232
Amneal Pharmaceuticals LLC
$212
CATALYST PHARMACEUTICALS, INC.
$199
Supernus Pharmaceuticals, Inc.
$194
HOSPIRA, INC.
$169
Bausch Health US, LLC
$159
Alnylam Pharmaceuticals Inc.
$144
MITSUBISHI TANABE PHARMA AMERICA, INC.
$138
Octapharma USA, Inc.
$130
Adamas Pharmaceuticals, Inc.
$120
Merz North America, Inc.
$117
Stryker Corporation
$105
Takeda Pharmaceuticals U.S.A., Inc.
$103
UPSHER-SMITH LABORATORIES LLC
$103
BANNER LIFE SCIENCES, LLC
$95
Otsuka America Pharmaceutical, Inc.
$90
HARMONY BIOSCIENCES LLC
$89
Celgene Corporation
$81
Assertio Therapeutics, Inc.
$72
PORTOLA PHARMACEUTICALS, INC.
$70
MDD US Operations, LLC
$66
Grifols USA, LLC
$63
Upsher-Smith Laboratories LLC
$56
Life Molecular Imaging Ltd
$54
Vertical Pharmaceuticals, LLC
$53
TerSera Therapeutics LLC
$47
Chiesi USA, Inc.
$47
Harmony Biosciences Llc
$39
AbbVie, Inc.
$38
Mitsubishi Tanabe Pharma America, Inc.
$38
AstraZeneca Pharmaceuticals LP
$35
Alfasigma USA, Inc.
$34
Mallinckrodt Hospital Products Inc.
$32
SANOFI-AVENTIS U.S. LLC
$30
Catalyst Pharmaceuticals, Inc.
$29
Merz Pharmaceuticals, LLC
$25
GRT US Holding, Inc.
$25
JAZZ PHARMACEUTICALS INC.
$24
Mallinckrodt Enterprises LLC
$24
GE HEALTHCARE
$23
Almatica Pharma LLC
$21
Exeltis, USA Inc.
$21
CHIESI USA, INC.
$17
Mallinckrodt LLC
$16
ARBOR PHARMACEUTICALS, INC.
$15
Promius Pharma LLC
$14
E.R. Squibb & Sons, L.L.C.
$12
Top 3 companies account for 56.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX COSMETIC · BOTOX THERAPEUTIC · BRILINTA · Banzel · Briviact · CAMBIA · CLEVIPREX · CLEVIPREX 50MG/100ML · COPAXONE · Cambia · DIVIGEL · DUOPA · Dayvigo · Duopa · EMGALITY · Enspryng · FIRDAPSE · FYCOMPA · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · Gamunex-C · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · Kcentra · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAMZARIC · NAPRELAN · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · OSMOLEX ER · OXTELLAR XR · Ocrevus · Ongentys · PANZYGA · PAXLOVID · POMPE - DISEASE · PRIALT · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · Qutenza · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Repatha · Rystiggo · SKYCLARYS · SOLIRIS · Soliris · TECFIDERA · TEGSEDI · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TREVO · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XARELTO · XCOPRI · XEOMIN · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · Zembrace · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for neurology in CA.

Looking for a neurology specialist in San Jose?
Compare neurologists in the San Jose area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
221
Per 100K population
11.6
County median income
$159,674
Nearest hospital
GOOD SAMARITAN HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sachdev is a mixed practice specialist, with above-average Medicare volume (top 7% in CA), with speaking/promotional industry engagement in the top 4% of CA peers, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sachdev experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Sachdev performed 14,200 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sachdev receive payments from pharmaceutical companies?
Yes. Dr. Sachdev received a total of $214,037 from 84 companies across 1,526 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sachdev's costs compare to other neurologists in San Jose?
Dr. Sachdev's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sachdev) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →